IGF::OT::IGF SBIR PHASE II, TOPIC 331: BIOPSY OPTICAL SENSOR FOR IN SITU TISSUE ANALYSIS
$1,499,984N44FY2016CANIH
Intelligent Optical Systems, Inc., Torrance CA
Investigators
Abstract
Current methods for guiding cancer biopsies rely almost exclusively on X-ray-, ultrasonic-, or magnetic-resonance-derived images. While these are far more accurate than the age-old technique of palpation, all three still essentially characterize suspected lesions based only on tissue density.
View original record on NIH RePORTER →